Comparison of site-specific gene expression levels in primary tumors and synchronous lymph node metastases in advanced gastric cancer
Authors:
- 21 March 2014
- journal article
- research article
- Published by Springer Nature in Gastric Cancer
- Vol. 18 (2) , 262-270
Abstract
Many malignant tumors consist of heterogeneous subpopulations of cells. This heterogeneity is associated with genetic characteristics. However, it remains unclear whether gene expression levels differ among specific sites of tumors in gastric cancer.Keywords
This publication has 33 references indexed in Scilit:
- VEGF and cortactin expression are independent predictors of tumor recurrence following curative resection of gastric cancerJournal of Surgical Oncology, 2010
- Differential gene and protein expression in primary gastric carcinomas and their lymph node metastases as revealed by combined cDNA microarray and tissue microarray analysisJournal of Digestive Diseases, 2010
- Hypoxia-inducible factor-1α expression predicts the response to 5-fluorouracil-based adjuvant chemotherapy in advanced gastric cancerOncology Reports, 2009
- Angiogenic Factor Thymidine Phosphorylase Increases Cancer Cell Invasion Activity in Patients with Gastric AdenocarcinomaMolecular Cancer Research, 2008
- Expression of Vascular Endothelial Growth Factor (VEGF) and Epidermal Growth Factor Receptor (EGFR) is an Independent Prognostic Indicator of Worse Outcome in Gastric Cancer PatientsAnnals of Surgical Oncology, 2007
- Regulation of tissue perfusion in mammals by hypoxia‐inducible factor 1Experimental Physiology, 2007
- Cellular response to tissue hypoxia and its involvement in disease progressionPathology International, 2005
- Loss of phenotypic expression is related to tumour progression in early gastric differentiated adenocarcinomaHistopathology, 2005
- Critical determinants of metastasisSeminars in Cancer Biology, 2002
- Expression of Thymidine Phosphorylase in Human Gastric CarcinomaJapanese Journal of Cancer Research, 1996